rs1553368576
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM1PM4PP3PP5
The NM_000251.3(MSH2):c.1818_1877del(p.Ser607_Glu626del) variant causes a inframe deletion change involving the alteration of a conserved nucleotide. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Synonymous variant affecting the same amino acid position (i.e. V606V) has been classified as Likely benign.
Frequency
Genomes: not found (cov: 32)
Consequence
MSH2
NM_000251.3 inframe_deletion
NM_000251.3 inframe_deletion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 9.13
Genes affected
MSH2 (HGNC:7325): (mutS homolog 2) This locus is frequently mutated in hereditary nonpolyposis colon cancer (HNPCC). When cloned, it was discovered to be a human homolog of the E. coli mismatch repair gene mutS, consistent with the characteristic alterations in microsatellite sequences (RER+ phenotype) found in HNPCC. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PM1
?
In a hotspot region, there are 7 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 14 benign, 13 uncertain in NM_000251.3
PM4
?
Nonframeshift variant in NON repetitive region in NM_000251.3.
PP3
?
No computational evidence supports a deleterious effect, but strongly conserved according to phyloP
PP5
?
Variant 2-47475082-TCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGA-T is Pathogenic according to our data. Variant chr2-47475082-TCAGCTTTGCTCACGTGTCAAATGGAGCACCTGTTCCATATGTACGACCAGCCATTTTGGA-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 408533.We mark this variant Likely_pathogenic, oryginal submissions are: {Uncertain_significance=2, Pathogenic=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
MSH2 | NM_000251.3 | c.1818_1877del | p.Ser607_Glu626del | inframe_deletion | 12/16 | ENST00000233146.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
MSH2 | ENST00000233146.7 | c.1818_1877del | p.Ser607_Glu626del | inframe_deletion | 12/16 | 1 | NM_000251.3 | P1 |
Frequencies
GnomAD3 genomes ? Cov.: 32
GnomAD3 genomes
?
Cov.:
32
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome ? Cov.: 32
GnomAD4 genome
?
Cov.:
32
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Pathogenic:1Uncertain:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
Hereditary cancer-predisposing syndrome Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 07, 2021 | The c.1818_1877del60 pathogenic mutation (also known as p.S607_E626del) is located in coding exon 12 of the MSH2 gene. This pathogenic mutation results from an in-frame 60 nucleotide deletion at positions 1818 to 1877. This results in the in-frame deletion of 20 amino acids at codons 607 to 626. This alteration is observed in an individual diagnosed with colorectal cancer and sebaceous epithelioma, which demonstrated loss of MSH2 and MSH6 expression on immunohistochemistry (IHC), and has a family history of Lynch-related tumors (Ambry internal data). Based on internal structural analysis using published crystal structures, S607_E626del removes a portion of MSH2 linking the MutS III and V domains, a region enriched in pathogenic variants (Warren JJ et al. Mol Cell, 2007 May;26:579-92; Ambry internal data). This variant was not reported in population-based cohorts in the Genome Aggregation Database (gnomAD). This amino acid region is generally well conserved through mammals. Based on the supporting evidence, this alteration is interpreted as a disease-causing mutation. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Color Diagnostics, LLC DBA Color Health | Feb 02, 2021 | This variant results in a deletion of 60 nucleotides in exon 12, resulting in an in-frame deletion of 20 amino acids from the MSH2 protein. To our knowledge, functional studies have not been reported for this variant. This deletion overlaps a region encoding a domain involved in interaction with the EXO1 and MSH6 proteins but the functional impact of this deletion is not known. This variant has not been reported in individuals affected with hereditary cancer in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. - |
Hereditary nonpolyposis colorectal neoplasms Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Invitae | Nov 23, 2016 | In summary, this is a novel in-frame deletion with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available for this variant. However, this deletion affects a region encoding the EXO1 and MSH6 interaction domains known to be important for the mismatch repair function of the MSH2 protein (PMID: 18822302, 9774676) This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a MSH2-related disease. This sequence change deletes 60 nucleotides from exon 12 of the MSH2 mRNA (c.1818_1877del). This leads to the deletion of 20 amino acid residues in the MSH2 protein (p.Ser607_Glu626del) but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at